«Cirrhosis, antibodies increase risk of poor outcome
for autoimmune hepatitis patients.»
Not exact matches
New research reports that cirrhosis at first diagnosis and antibodies
for the soluble liver antigen / liver pancreas antigen (SLA / LP) are major risk factors
for poor short - and long - term outcome in patients with
autoimmune hepatitis.
People with IBD are also at an increased risk
for certain liver diseases, such as primary sclerosing cholangitis (found primarily in those with ulcerative colitis),
autoimmune hepatitis, and primary biliary cirrhosis.
Non-Acidified MMS: Medical - type patents describe the use of stabilised sodium chlorite in oral, topical and intravenous applications
for treating
autoimmune diseases and chronic infections, also
hepatitis and lymphoma, and
for neutralising the neuro - toxic effects of acetaldehyde produced by Candida and other fungi.